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Inuodutüon
The produets of the extreme polymorphic genetic Systems, which aie
called major histocompatibihty complexes (MHC), play important roles in
the immune system Α number of immune response (Ir) genes which regu-
late the level of response to specific antigens have been mapped to the same
region MHC molecules participate in the interaction of Τ cells with foreign
antigens, possibly providing binding Sites for foreign struetures such as
viruses and soluble antigens and thus permitting their successful recogni-
tion by Τ cells T-cel) interaction with antigen IS MHC-restncted, which
implies that Τ cells must possess reeeptors which simultaneously recognize
both the self-MHC molecule and the foreign antigen Dunng the last decade
expenmental evidence for this phenomenon has been widely reported in
mouse and man
In this chapter, in vitro observations are desenbed concermng the rec-
ognition of human minor transplantation antigens by cytotoxic Τ cells in
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thc context ot sell-MHC The antigens recognt/ed in the '\stcms descnbcd
below arc the male histocompatibiht\ antigen. H-Y. and other mmor lns-
tocompatibilitv aniigens In both cases. the class-[ mole< wies of thc MHC
are tnvolved in ihe interactions of the effector evtotoxie Γ cells with thcn
targets Detatled analvses of these Systems using cell lmes and cloncs ha\c
shown that human c>totoxtc Τ cells recognize antigens in a manner analo-
gous to that of cytotoxic Τ cells in the mouse. We have taken advantage ol
the a\ailabiht\ of cells from bone marrow-grafted patients which had been
pnmed to mmor histocompatibihty antigens in vivo in Order to stud> the
role of evtotoxie Τ cells in ihcir recognition The results of the in \itio
studies of patient matenal allowed us to draw some conclusions towaids its
clinical rcle\ance and hopefull> can contnbute to the understanding of the
role of non-MHC antigens in organ transplantation
Cell- Mediated L\ mp/ioh s/s
Τ cells are \ery heterogeneous in function as well as in expression of
surface markers Onh one of the T-cell subsels, namely the T-effectoi cells
will bediscusscd This T-cell subset can be furtherdividcd into functionalh
different T-effector cell subpopulations, of which the cytotoxic Τ Kmpho-
c>tes (CTLs) will bc desenbed below.
In the early modeis of cell-mediated lmmunity the effector populations
were obtained from expenmental animals or humans who had been lmmu-
nologically challengcd in vivo. Immunizations with allogeneic matcnals
usually resulted in high levels of cytotoxicity and they can serve as a model
for the analysis of transplantation. One of the best characten/ed effector
cells in these in vivo allogeneic modeis is the CTL [19]. The first unequiv-
ocal observation of lymphocyte-mediated cytotoxicity was made b\ (7m-
aeits [46] who observed that thoracic duet lymphocytes, harvested from
dogs which had rejeeted their kidney allograft, were capable of lysing donor
cells in vitro. Subsequent observations have confirmed the generahty of
that findmg, and the lymphocyte-mediated destruction of many different
target cells have been reported [89].
In man, similar studies were reported in situations where allogeneic
sensiti7ation oecurred in vivo For obvious ethical reasons, the need for a
homologous in vitro system to replaee the in vivo sensitization Step was
clear The availabihty of an in vitro technique for thc induction and differ-
entiation of specific cytolytic effector Τ cells has made a sigmficant contn-
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buuon lo ihe undcrstanding of thc role oi the MHC antigens in thc immune
responscand has pio\ided an in vitro model ofthc homograh reaetion The
so-called cell-mediatcd lvmphohsis (CML) technique was developed b\
Li^htboch et a! [70] and consists of two in vitro phases an induction phase
in which KmphoKtic effector cells are induccd and an effectoi phase in
which the effector cells lvse chromium-labcled target cells Thc gcncration
of effector cells in the first step IS necessarv in oider to obtam measuiable
cvtotovicitv in the second step In addition thev used hmphocvtes trans-
tormed into blasts bv treatment vvith phvtohemagglutinin as thc source ot
target cells The CML assav asjust desenbed used relativel\ laige numbers
of cells but a micromethod was introduced where the cells were incubated in
plates [102] The disadvantage of this svstem was that at the end ot the
incubation penod the supematant from each well had to be remo\ ed foi
gamma counting This disadvantage was abolished bv the technical nn-
provement for harvesting the supernatants in the CML assa\ with a simple
cartndge svstem [51] Precise details of the method currentlv used in our
laboraton» to detect evtotoxie T-cell responses in vitro have been given
elsewhere [40]
Recogmtion Stmctures foi C\toto\it 7 L\mphot\tes
Class-I Molecules
Class-I molecules (H-2K. D and L in the mouse, and HLA-A Β and C
in man) are transmembrane glycoproteins with a molecular weight of
44 000 daltons The major portion of the molecules is on the outside of the
cell membrane and is associated with a 12,000-dalton polvpeptide called
ßi-microglobuhn The genetic analysis of the HLA complex was facihtated
by Computer analvses of reaction patterns obtained from large numbers of
antisera tested against random leukocyte samples [95] Recogmtion of the
multiple alleles of the three HLA class-I loci was facihtated by a senes of
international cooperative Workshops Recently, also biochemical anal>sis
of the gene produets of the class-I loci demonstrated a senes of 44,000-
dalton glycoprotein chains [116], showing the presence of more than three
class-I-like struetures Whether these can serve as recogmtion struetures for
CTLs is unknown The class-I molecules can serve as target determinants
for CTLs This is presumed since target determinants recognized in CML
are highly associated with the serologically defined HLA specificities [16
26, 47-49, 69, 80, 113] and, in addition, demonstrated by the use of a
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human Β lvmphoblastoid ccll hne which lacked the serologically defincd
HLA-A2 antigcn and had lost susceptibihty to lysis by HLA-A2-specific
CTLs [2] Whether or not alloantisera and CTLs recogmze the same epi-
topes on class-I molecules IS a topic of current investigation and will be
discussed bnefly in this chapter
Class-II Molecules
The class-II molecules (H-2 I region products in the mouse and HLA-
D region products in man) consist of two separate glycoprotein chains with
molecular weights of approximatelv 34,000 and 28,000 daltons Both
chains are integral membrane proteins and have a large extracellular and a
small intracellular region The products of the class-II genes are maml>
responsible for the prohferative responses in mixed lymphocyte culture
They can be identified b> serological as well as cellular techniques At least
three distinct human class-II molecules exist HLA-DR, DC and SB [53]
Recently analysis of the HLA-D region at the molecular and DNA
level became possible and will lead to the further charactenzation of the
class-II molecules [53, 99] It is possible to detect cytotoxicity towards class-
II HLA-D/DR antigens or determinants closely linked to them [1, 27 55
76] and to DC antigens [109]
das·;-! lanants
In 1965 Baile\ and Kohn [3] provided the earhest evidence of H-2 gene
mutation by the discovery of lncompatibilities within inbred strains In
mbred strains of mice, individuals were found that were capable of rejecting
skin grafts from mice of the same strain The generation and detection of
these mutants has been reviewed [59] Α rather high rate of mutations is
observed for the H-2K allele [60] Structural differences in the bm senes of
mutants of the H-2K allele ha\e been shown by biochemical analysis [84]
At the functional level, the differences have been confirmed by skin grafting
and functional assays such as CML [4, 78, 79, 120]
Evidence has been presented for the occurrence of analogous mutations
in man In 1976, individual Variation within a serological defined specific-
ny, ι e HLA-Bw 35, could bedetected by CTLs [35] CTLs were generated,
between HLA-A, Β and C identical sibhngs, which specifically recognized
two different types of HLA-Bw35 antigenic determinants which are still
serologically indistinguishable Subsequently, by the use of CTLs, subtypes
(vanants) have been descnbed for HLA-A2 [12, 41, 52, 90, 91, 108], HLA-
A3 [14], B7 [108], B27 [18], B4Q [73], and Bw44 [56] For some of these
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subt\pes defined b\ alloimmune-specific CTLs biochcmical anahsis
showed structuial dillerences thcrebv indicdting a basis foi thc abcrrant
reaaion pattems obtained with CTLs [Π 81 92]
It IS ob\ious that Information is needed about the role ot ÜILSL \anants
in human oigan transplantation If so ihc use of unrelated donois should
lakc into account the presencc of subtvpes or vanants Fsixualh SIIUL
HLA-matched unrelated donors also in bone-marrow giaitins ne rtgu
larh used
\c;/; HL 1 Intigcns
Evidente for the existence of non-HLA target determmams iti_ogni/ed
b\ in vitro generated CTLs between HLA identical related and uniLlaied
combinations has been presented bv several aathors [48 ό"7 ""ι "^ 96 97
106] The nature of these non-HLA target d u rminants lecogni/ed b\ in
vitro CTLs could however not be deduced 1t s possible that some of these
icactions lepresent vanants It seems hkely that CTLs specific for non-HL\
antigens will oeeur following in vivo immunization ι e as a result ot blood
transfusion pregnancv graft rejection and graft-versus-host attack and the
chance of finding non-HLA antigen-specific CTLs mav be increased in
those situations With the use of in vivo generated CTLs a numbei of
leports desenbed membrane diffeiences detected bv CML but not detected
b\ conventional HLAt\ping[2i 29 11-33 16 42 54 68 ~*4 75 88 90
106a 112 114 117 118 121 122] Thc natuie of some ol these target
determinants recognized b> in vivo generated CTLs and the mechanism bv
which thev can be recognized will be discussed below
\1HC Rest na ίο η of CTLs
Histon and Models
Oldstone et al [85] desenbed Variation in susceptibihtv to infection
vuth lymphocvtic chonomeningitis virus (LCMV) in congeneic mice differ-
mg only at H-2 (H-2q mice were more susceptible than H-2k mice ) These
vanations to LCMV (which is apparently a T-cell-mediated lmmunopatho-
logical process) may be due to genetically determined differences in T-cell
responsiveness The original expenment by Zinkemagel and Doheitx [123]
established the fundamental importance of the role of the MHC in T-cell-
mediated lmmunity namely, virus-immune Τ cells obtained from LCMV-
mfected mice showed only in vitro cytotoxic activity when assayed on H-
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2-compatiblc LCMV-mfecled fibroblasts argcl cells from H-2-incompati-
blc donors were not Ivscd [123]
Dunng thc following vcars numerous studies in rodents ha\e shown
that thc activation of Τ hmphocvtes b\ different forcign antigens IS
restncted bv self-MHC molecules Thus Τ lvmphocytes appear mainlv to
be able to recogni/e forcign antigens when the\ are presentcd to thc Τ l\m-
phocvtes on cells which share some homolog\ of the H-2 region vuth thc
animal under study
The observations with LCMV were soon confirmed and seemed to be
also applicable to a senes of other viruses ectromeha (mouse pox) vaccm-
1a sendai mfluen/a herpes simian (SV40), cytomegalo, alpha viruses and
also for tumor-associated viruses [for review see ref 124] The H-2-rcstnc-
tion phenomcnon was not hmited to vnuses only Independcnth and at thc
same time as /mkeinagel and Dohcrt\ [123], Shearei [101] disco\ered in
1974 that MHC-restncted T-cell-mediated cytotoxicit> can be gencrated
agamst svngeneic Kmphoid cells whose surfaces had been chemicalK mod-
lfied MHC restnction of CTLs was also found for non-H-2 alloantigens ι c
minor histocompatibihty antigens [6], including the male specific H-Y anti-
gen [34] These reports and the manv which followed, show that a main
function of class-I molecules is to participate in the interaction of CTLs
with their targets MHC restnction is not unique to cytotoxic Τ cells as
discussed extensively elsewhere in this volume
The underlying mechanism by which cytotoxic Τ cells recogm/e self-
MHC and foreign antigen can be explained by two distinct modeis (a) the
altered-self model, and (b) the double-receptor model In addition several
other modeis shanng some of their features have been proposed In the
altered-self model Τ cells are equipped with a Single receptor which is
specific for a neoantigenic determinant formed by a complex of self-MHC
and foreign antigen on the target cell, or one receptor for the complex of the
unaltered-MHC molecule and antigen In the two T-cell receptor model Τ
cells have two recognition molecules one is specific for self-MHC restnc-
tion molecule and the other tor foreign antigen This is called the dual
recognition hypothesis The current thoughts about the two modcls have
been recently summanzed by Berzofski [5] The first clear demonstration of
the involvement of products of the human MHC in T-cell-mediated cyto-
toxicity was reported by our own group [36, 37] and concerned the recog-
nition of the male-specific minor histocompatibihty antigen, H-Y Subse-
quently, HLA-restncted cytotoxic T-cell responses have been descnbed for
\iralh infected taiget cells hke Epstein-Barr virus [94 115] mfluen/a virus
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[11 72] measles \ π us [61] hcipcs Simplex \irus [98] human estomcgalo-
\irus[91] mumps \ iius [66] and human T-iell lcukcmia h m p h o m a \111ib
[82] hapun modüud im^a ulls like diniirofluoibcn7cne-conjugaied 01
dinitiopheml-conjugated taiget teils [22 2>] inni t rophen\ l [100] and flu-
oitscein isothiotxanate-ionjugated target teils [28] solitbk aii!ijai\ hW
letal tdll sei um [81] and punficd piotein d e m a t n e o( tubeit ulin [119]
The lole ol the tlass-I moleculcs and the thmcal implitalion ol tlu
aη11 -\ 11 a 1 CTL iesponses are treated in more detail clsewhere in ihis \ol-
ume The HLA-restutted CTL responses agamst minoi his totompat ibi lm
(1 e minor H) antigens will be rcwewed below and are based on our expei-
iments done over the last \eais on the detection ot minoi Η antigens and
then possible implitations in human oigan transplantation
I RcstiiLicd C ILs Dnetted aqaimt the
\fmoi 11amplantatum Intigen Η }
The in\olvcmcnt ot H-Y (at that time called Y-factoi) in homogratt
rejection had been postulated by I uhnald and Slimsei [24] in 195") The
term ΗΛ antigen was introduced by ΒιΙΙιηφαηι andSiheis [13] since the \
factor IS a transplantation antigen determined b\ a histocompatibilm gene
comparable in all respects to the antigens responsible for homogratt rejec-
tion
In vitro immune response against the human male spetific histocom-
patibiht\ antigen H-Y was detected in a multi-transfused iemale aplasiic
ancmia patient 1 e patient 1 She received a bone marrow graft from her
HLA-identical brother There was a temporarv take but the graft was
rejetted after 20 da\s Rejection was aecompanied by a ->pontaneous reco\ -
cr\ of the patient's bone marrow hemopoietic function
Investigation b> the use of the CML technique showed unambiguouslv
that the post-transplant penpheral blood lymphocytes (PBLs) of this patient
(le patient 1 HLA phenotype HLA A2, A2, Bw44, Bw60 Cw3 Cw5
DR4 DRw6) exhibited strong cell-mediated cy totoxic reactions specific for
male HI A-A2-positive target cells [36, 37] The results obtained with the
HLA-A2~restncted anti-H-Y CTLs from the patient are shown in table I
As shown in table I, cells denved from three HLA-A2-positive females
(from a randomly selected panel of 45 HLA-A2-positive women) were also
lysed (although at a lower level) Since we obtained our HLA-restncted
anti-H-Y CTLs from an in vivo sensitized patient, 1t is possible that small
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1 ubk I Pallern of hsis b\ ( Λ 1 s iiom patient 1 against target cells liom unrclatcd indi-
% iduals
C ML Seiologiuil
positive
76
42
upmg for HL Λ Λ2
negame
0
37
Sc\ of
male
73
0
HLA-A2-positive target cclls
femalc
3 a
42
B\ blud\ing the reactivin palterns of HLA-restncted anti-H-Y CTLs onc can bc con-
(ronled uith \dnanls at ihc Jcvcl of Ihc spccific rcstncting element (ι e HLA-A2 mole-
cule) as ucll as ai the le\cl of the subjeet of resinction the anügen H-Y This table exeludes
!hc rcsulls obtaincd b\ lnvcstigating HLA-A2-rcstnctcd anti-H-Y CTLs agains' Kmpho-
tvtes d e m cd from (1) HLA-A2 vanants [41 45] and (2) abnormal sex chron nsome
constuutions [43]
J
 The le\el of Ksis IS low but significant
numbers of T-ccll clones ma> have been directed against other minor Η
antigens The presence of these minor Η antigens in the males may ha\e
been masked b> the H-Y-specific lysis On the other hand, we ma> be
dealmg with the phenomenon 'neoantigens can resemble alloantigens' It
has been shown thai Τ cells which show antigen-specific MHC-restncted
reactivit\ can also demonstrate cross-reactivity Namely, MHC-restncted
CTLs can recognize not only modified seif but also histoincompatible (i e
forcign) MHC molecules and/or modified foreign MHC molecules This
obser\ation is often referred to as 'the seif plus foreign («neoantigen)
resembles allo' phenomenon [10, 71]
In our stud> all 3 women also had, in addition to HLA-A2, the HLA-
Bw60 antigen in common Analysis on the clonal level of the reactivitv
patterns of the HLA-A2-restncted anti-H-Y CTLs against these HLA-
Bw60-positive female donors may provide us with more definitive an-
swers
It is worth noting that the level of HLA-A2-restncted anti-H-Y lysis
seemed to dechne with time and the gradual waning seemed to be associ-
ated with the patient's reeovery Nevertheless, it was possible to restimulate
the H-Y-specific lysis by an in vitro Stimulation using lymphocytes from an
HLA-A-, B-, C- and D-identical unrelated male donor, instead of the HLA-
ldentical male sibling donor cells. In that way effector cells were formed
with the expected specificity for HLA-A2 male target cells. By using this
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piotocol A2-restncted H-Y-specific CTLs can bc obtaincd up to the
prcsent timc - 8 vears after gratting Our first observation was tonlu med in
2 additional cascs (out of a group of 12 femaie aplastic anemia paiicnts
sludied) which showed cxactiv the same phcnomenon nameh HLA-
restnctcd anti-H-Y immunity [38. 39] These 2 cases (patients 2 and 1) weie
femaie siblings with severe aplastic anemia They had boih been lmmu-
ni/ed b\ multiple blood transfusions (and not by bone mairow transplanta-
tion) and in addition patient 2 had had three pregnancics The pattein ol
Ksis obtained with effector cells of patient 2, after restimulation in \itio
with the lymphocytes from her healthy HLA-identical male sibhng showed
HLA-A2-restncted H-Y kilhng comparable to that in our first case reported
earher Thus η follows that blood transfusions and possibly piegnancies are
sufficient in themselves to induce HLA-restncted anti-H-\ c\totoxicit\
and that bone marrow transplantation IS not a necessary prerequisite [38]
Singal et al [104] demonstrated the presence of HLA-A2-rcstncled anti-
H-Y CTLs in multiparous females
In vitro studies with the lymphocytes ofour 3rd patient re\ealed HLA-
restncted CML reactivity to the H-Y antigen in which the self-HLA-A2 oi
HLA-B7 molecule was required [39] The results obtained with the HLA-
A2 and B7 anti-H-Y CTLs from the 3rd patient (HLA phenonpe HLA A2
A28, B7. Bw62, Cw3. DR1, ORZ) are shown in table II. As shown in tablc
II, cells denved from an HLA-A2-negative, B7-negative femaie donor wcie
also lysed, although at a much lower level than was observed for HLA-A2-
or B7-positive male target cells Those target cells represent the only dis-
crepancy in the tests with the CTLs from patient 3
Interestingly, Pfeffer and Thorsbv [90] descnbed the detection of HLA-
A2- and B7-restncted anti-H-Y CTLs after kidney graft rejection Α prc-
viously nonsensitized (never transfused or pregnant) femaie patient acutely
rejected a kidne\ graft from her HLA-identical brother. Shortly after the
graft loss, lymphocytes obtained from the patient showed cytotoxic activity
against male target cells shanng the HLA-A2 and (or) B7 antigen with the
patient. The latter results and the results which we obtained in our 3
patients suggest that H-Y-specific cytotoxic Τ cells demonstrate preference
for certain (ι e A2 and B7) restncting elements.
To gain insight into the apparent dual specificity of such CTLs (A2 plus
H-Y, Β7 plus H-Y) at least three basic cellular approaches can be used
monolayer absorption, cold target Inhibition and cytotoxic Τ cell clones
The results of a cold target Inhibition expenment are shown in table III The
HLA-A2- and B7-restncted anti-H-Y CTLs were tested against only one
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1 ahh II Patlcin ol hsis b\ ( IL s Irom palicnl λ againsi u ig i l (.ells from unrclakd indi
\ lduals
t \1L Serological t\ping for Λ2 and \Γ Sex ol HLA \2 ind or
B7+ largcl CLIIS
A2+ B7+ V2+ B7- A2-137+ Λ2- 137- male lemale
+ 12 ^2 7 Η 51 0
3 11 2 16 0 18
This tablc extludes ihc results obtained b> lmesügation of HLA-A2- and B7-rcstnctcd
anti ΗΛ CTLsagainst lvmphoc\tesden\ed Irom (1) HLA A2 vananls and (2) abnormal
se\ chromosome conslitutions (scc also legend to table I)
1
 HLA-A2-negative and B7-negaüve female donor
Iabk III Specifit Inhibition of HLA-A2- and B7-reslncled anti-H-Y CTLs b\ cold largci
cclls
C old inhibaors dddeda L>sis of 5lCr-labeled target cells %
Nonc
A2-\e B7-\e male
A2+ve male
B7+ve male
A2+ve B7+ve male
Λ2+\ε female
B7+ve female
" Hol cold ratio 1 10 the competilive Inhibition protoeol has been desenbed in detail [40]
Effector target ratio 5 1
type of target cell - enher A2 or B7 For example HLA-A2-posttive male of
isotope-labeied target cells and unlabeled target cells of either HLA-A2-
positive male cells or HLA-B7-positive male cells were added Effecttve
reduction in lysis was observed only when cold target Inhibitors of the same
HLA specificity as the labeled target cells were added for example labeled
A2+ve cf
55
56
9
60
10
60
58
B7+ve cf
65
66
72
19
9
60
63
Cioulmv ->4
HLA-A2-positi\e male taiget cells wcic inhibilcd b\ unlabeled HLA-A2-
posime male targei eells bul not b\ unlabeled HLA-B7-positi\e male tai-
get cells (tablcIH)
Eaih C TL subpopulation IS restneted to recogm/ing the foieign antigen
(H-\ and olhei minoi Η antigens as will be discussed latci) in association
with onh one HLA molcculc Sensiti/ed killer cells which recogni/ed two
combincd antigens HLA-A2 Η-Υ and HLA-B7 H-\ could indeed be
dmded mio two populations one directed against HLA-A2 ΗΛ and the
otheragainst HLA-B7 H-\
The consequence ot these distinct subsets of cytotoxic Τ cells is that the
indmdual is not dependent on a Single allele that can sene as a souice of
iestnttion molecule for Τ cells Clonal distnbution of HLA-iestncled anti-
ΗΛ -specific CTLs has been descnbed also b> Pfeftei and Ihoisln [90]
using cold target Inhibition tcsts
Clinual Rele\aiue of the Η- Υ llloantigenic S\stcm
In order to determme the possible influence of H-Y lncompatibihties on
the results of human kidnev allogiaft transplantation. we examined cada\ ei ic
renal allograft suivnal data (collected under the auspices of Eurotransplant)
at 2 years after transplantation for the influence of sex and HLA The retro-
spective stud> showed a significant difference between HLA-A2 tcmales
recei\ing HLA-A2 male kidneys and non-HLA-A2 females recening non-
HLA-A2 male kidne>s The H-Y incompatibiliües in donor-iecipient com-
binations sharing the HLA-A2 antigen resulted in a 38% graft surmal at
2 \ears in contrast to 58% in the HLA-A2 non-shanng group [38]
To cxplain these findings and those reported bv Pfeife) and Ihoisln
[90] the follovung hypotheses can be considered (1) a peculiar immunofe-
nicit> of the HLA-A2-H-Y complex (and HLA-B7-H-Y complex) (2) tne
mvolvcment of Ir genes in the anti-H-Y response Α similar phenomenon
has been suggested in the mouse [103] At the moment lt is difficult to
choose between these two hypotheses Opel: and Teiasaki [87] investigated
the influence of sex on histocompatibility matching in a large senes of kid-
ney transplant recipients They observed a stnking difference in renal allo-
graft survival between the sexes when matching for HLA-A and Β antigens
Α highly significant correlation was found between HLA matching and graft
survival in male patients Additionally, the latter observation was most
stnking in male patients with blood groups other than Ο
Some other studies have not been able to detect any influence of sex in
kidney transplantation [21, 86] but in those studies male to female trans-
Recogmtion and fmphcation of Human Minor Η Antigens ^
planis in HLA.-A2 or HLA-B7-compaiiblc combinations were nol specifi-
calK in\cstigated
In bone marrow transplantation thc Situation IS as follows Despue thc
fact that aplastic anemia and leukemia patients are transplanted with bone
marrow from an HLA genot\picall\ identical sibhng, rcjection and gratt
versus host disease (GVHD) still remain a senous problem in human bone
marrow transplantation The results rc >orted on the effcct of se\ match
between bone marrow donor and recipient are rather conflicting Stoih et al
[110] reported a stud\ of prognostic faetors associated with GVHD and
survnal in transplanted aplastic anemia patients. They found that. using a
multifactonal anal>sis. thc occurrence of GVHD and survival of patients
with aplastic anemia was strongly influenced by whether or not donor and
recipient were matched for sex Male patients seemed to have a high mci-
dence ol GVHD However, the same group [111] recently reported that
recipients of marrow from donors of the opposite sex have survivals equal
to that of recipients of marrow from sex-matched donors Α pubhcation bv
Boitm et al [17], on the behalf of the Advisory Committee of the Interna-
tional Bone Marrow Transplant Registry, suggested that the use of male
donors was preferable to female donors because of a higher rate of engraft-
ment, less severe GVHD and a higher 1-year survival rate. Indeed, investi-
gation of their detailed analysis showed that 64% of male recipients of
marrow from female donors had GVHD (male —> female 31 %. female ->
female 71 %, male -> male 42%) Additionally, the detailed analysis of the
number of 1-year survivors showed that male recipients of bone marrow
from female donors had the worst survival rate. In order to obtain a correct
insight into the influence of sex combinations on the outcome of bone mar-
row transplantation, I think the HLA-A2- and B7-positive recipients
should be investigated separately. As discussed earher in this chapter, H-Y
associated with HLA-A2 and probably also with HLA-B7 seems to act as a
streng immunogen in females. In addition, involvement of the HLA-A2
and B7 molecules in associative recogmtion of other minor Η antigens is
very strikmg and will be desenbed below.
Class-I-Restncted CTLs Directed against Minor Η Antigens
Simultaneously with the descnption of the estimation of the number of
major Η loci in mice, Snell [105] indicated the existence of what he called
rare h genes coded for by separate histocompatibihty loci. He noticed at
that time the difficulty with which these loci could be detected: 'Is there an>
way that these loci can be discovered? The answer would appear that there
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IS no simple method ot findtng them but that bv thc usc of somcwhat labo-
nous mcthods the\ can e\cntuall\ be brought to light Those Statements
are still truc especialh for the human minor Η loci COUIILL et al [20]
dassified ihe tissue antigens which aecount for the phenomenon ofgiait
rcjcction into two main groups aecording to the strength vwth v.hich the\
lead to graft rejection (1) major Η antigens which cause rapid acute graft
rejection and (2) minor Η antigens which aecount tor comparatneh slov\
and more chronic graft rcjections
The minor tiansplantation antigen H-Y coded for bv the \ chiomo-
some has alread> been discussed above Other minor Η antigens which in
mice are coded for bv as marn as 30-100 genetic loci which are spiead all
o\er the genome, act more stronglv than others in graft rejection and toi the
majontv onh a few allehc forms have been desenbed [58] With Special
regard to the cellular recognition of minor Η antigens, Be\an [6-9] exten-
siv ely anal\zed the cytotoxic T-cell responses towards mmor Η antigens in
association with MHC molecules
Recentlv considerable Information has been obtained about the possi-
ble existence of minor Η antigens in man The oecurrence of a severe
GVHD in a bone marrow-transplanted male acute mveloid leukemia
patient prompted us to investigate the in vitro cytotoxic activitv of the
patient's post-transplantation lymphocytes The patient (HLA phenot\pe
HLA-A2, A2, B27, Bw62. Cwl, Cw4 DR1, DR4) had been transplanted
with bone marrow from an HLA-identical female sibhng donor and füll
chimensm was induced His chnical recovery was compheated bv severe
chronic GVHD The initial expenment [42] demonstrated that post-trans-
plant lymphocytes had strong cytotoxic activity. as measured b\ the CML
assay, against his ovvn pre- but not post-transplantation lymphoevtes
As expected the patient's post-transplant lymphocytes did not react
with the target cells from the bone marrow donor Thus, the transplanted
lymphocytes (ι c donor cells) differ for a non-HLA factor (which wc desig-
nated as minor Η antigen) from the patient's own pre-transplant lympho-
cytes Subsequently, the patient's post-transplant lymphocytes were ana-
Iy7ed more extensively [44] In order to do so, large quantities of the
patient's CTLs were needed They were obtained using the following proto-
col CTLs with specific cytotoxic activity were generated by stimulatmg the
oatient's post-transplant lymphocytes with either his own pre-transplant
lymphoevtes or with the lymphocytes from an HLA-A-, B-, C- and DR-
ldentical unrelated healthy individual. After 6 days of pnmary in vitro
sensitization, cytotoxic T-cell hnes were grown (by the use of feeder cells
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I it; l I \sis pattern in patient s familv
plus lectin and/or T-cell growth factor) and were tcsled for specific cvtotoxie
activitv and subsequently fro/cn in small ahquots. In that wa\. large
amounts of CTLs were harvested. stored and used as typmg rcagents
The results obtaincd using as target cclls lymphocytes from (i) ihc
patient's own family (2) a comprehensive number of randomh chosen
unrelated hcalth> panel donors, and (3) relatives of the positi\el\ Ksed
panel donors, are as follows
(1) Investigation of patient's familv revealed, besides absence oi t u o -
toxiciu against the l\,mphocytes of the bone marrow donor (ι e D), dtlter-
ence in succeptibihu to lysis between ULA-nientical siblines (03 04. 05)
The latter observation mdicates that we must bc dealing with a non-HLA
target determinant (fig 1)
(2) The results of the panel stud> are shown in table IV and lllustratc
that the non-HLA targel determinants could only be recognized lf onc of the
three different HLA class-I molecules of the patient were present on the
target cells The panel analysis shows that the minor Η antigen assoeiated
with HLA-A2 has high gene frequency in the random population in con-
trast to the minor Η anligen assoeiated with B27 Neverthcless, we ha\e as
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The l n c i d t n c t s o/ t\ lolo\ii_n\ o b u u n t d agJinsl tei ls wilh or wi thoul o i u ο ' ι In. Ü I K L
a s i i R t i n g n i o k e u k s IS shown Target CLIIS t a r n i n g morc than onc it.slin.iing d u i u n i i n
not i n t l i u h d Targel (.LÜS Irom (.slahiished HLA \ 2 ( a n d H L A B27) \ a n ints aix L\Lludt.d
l iom ihis btudv
labli I C ompc t i i ivc Inhibit ion c x p e n m e n l s
••'Cr labelcd targei cclls Lvsis % Cold Inhibitors added Lvsis "O
1 H L \ - \ 2 + Bw62- B27- 99 a none
b HLA A2+ Bw62- B27- 19
c HLA-A2- Bw62+ B27- 99
2 HLA Λ2+ Bw62- B27- 97
A2- Bw62+ B27- 38
a none
b HLA-A2+ Bw62- B27- 26
c HLA-A2- Bw62- B27+ 93
a none
b HLA-A2- Bw62+ B27- 19
c HLA-A2+ Bw62- B27- 53
d HLA-A2- Bw62- B27+ 34
The inhibiton capacitv of non labeled target cells carrying only one of the restncting
molcculcs plus the minor Η antigen was measured The ratio labeled unlabeled targtl cclls
was 1 10 The percentage Ksis for etTector target ratio of 50 1 ts shown The competmve
Inhibition protoeol has been desenbed in detail [40]
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2 L\sis pallcrn of HLA-restncted anti-minor Η antigen CTLs
>et no data to indicate whether or not the non-HLA antigen which IS seen in
association with HLA-A2 is the same as those seen in association with
HLA-B27 and HLA-Bw62
(3) We investigated the relatives of the positively lysed panel members
The family studies showed a codominant mode of inhentance of the HLA-
restncted minor transplamation antigen In 2 HLA-A/C tross-over fami-
lies, the target determinant segregated with the HLA-A2 antigen, indicating
that ifthis minor Η antigen is coded by chromosome 6, lt is located telo-
menc from HLA-C An example of the lysis pattern of the HLA-A2-
restncted anti-minor Η antigen CTLs in 1 HLA-A/C cross-over family is
shown in figure 2
In order to identify the involvement of distinct subsets of CTLs with
receptor specificity only for one restncting Clement, cold target competitor
expenments and analyses at the clonal level were carned out The results of
cold target cell Inhibition expenments (table V) and T-cell clonal analysis
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(table \I) showcd unequivocallv that we arc deahng with thice discrctc
subsets of c\toto\ic Τ cclls one specific for minor Η antigcn plus HLA-A2
one specific ior minor Η antigcn plus HLA-Bw62 and anothci one specific
for minor Η antigen plus HLA-B27
Inhibition of Ksis of thc labeled larget cells IS onh obscr\ed lt cold
taiget cells are added uhich carr\ the samc class-I-iestncting moleculc toi
example the pcrcent Ivsis of target cells 1 is onl> inhibited b\ addition oi
cold inhibitoi cells b and not bv addition of cold Inhibitor cells c uhich
carrv anolher class-I-restncling molecule (1 e HLA-Bw62)
Distinct subsets of Τ cells showing receptor specifieitv exclusivelv Ιοί
only one HLA gene product can also be demonstrated b\ anaivsis at the
clonalle\el Forexample clone 1 reactsonly with HLA-A2+ B27- B\\62-
target cells clone 4 reacts only with HLA-A2- B27+ Bw62- target cclls
In summary CTLs were harvested from a recipient of bone manow
from his HLA genotvpically identical sibhng That recipient was sulfenng
from severe chronic GVHD These CTLs showed extremelv high c\toto\-
icity in vitro against the patient's own pretransplant lymphocues dittei-
ences in susceptibihty to Ksis between HLA-identical sibhngs and pos>ti\e
reactions in CML against target cells which carned the ciass-I antigens (i e
HLA-A2, Bw62 and B27) of the patient These results stronglv suggesl thc
presence of one (or more) minor Η antigens recognized b\ MHC-restricted
CTLs At the clonal level η could be demonstrated that distinct c\toto\ic
T-cell subpopulations demonstrate their specificüy for the difterent class-
I-restncting molccules
Evidence for the existence of human minor Η antigens has also been
reported by other investigators [25 106a, 112] Llkins et al [25] descnbed
the recognition ofa human minor alloantigen by lymphocytes demed from
a multitransfused aplastic anemia patient They showed that the lvmpho-
cytes from that in vivo sensitized patient, restimulated in vitro using HLA-
mismatched stimulator cells recognized a non-HLA antigen in an MHC-
restricted fashion Testing of the patienfs lymphocytes against a panel of
lymphocytes from unrelated individuals indicated that the class-I molecule
B7 was involved in the recognition of the minor Η antigen SubsequentK
Tekolf and Shaw [112] demonstrated that in vivo pnming by pregnancv
seemed to be sufficient to generate cytotoxic Τ cells against a human minor
Η antigen PBLs from a normal female, after secondary in vitro Stimulation
with cells from an HLA-A-, B-, C- and D-matched donor showed strong
cytotoxicity against a minor Η antigen in an HLA-restncted iashion The
restncting molecule was again HLA-B7
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1 abk \I Clonal anahsis of the HLA-A2 Bw62- and B27-resincled anti-minot Η antigoii
CTLs
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1
->
3
4
5
6
E T 1
8 1
4 1
18 1
3 1
25 1
25 1
a
 Effector targct ratio
b
 Percentagc hsis
Target cells
HLA-A2+
B27-
Bw62-
59
81
1
7
HLA-A2-
3
3
0
52
2
B27+
Bw62-
HLA-A2-
B27-
Bw62+
4
1
1
24
13
Climcal Rele\ance ofthc Minor Η Antigen System
The results in bone marrow transplantation are still far from satisfac-
tory One of the major problems IS GVHD which affects approximateh
50-60% of the patients grafted with bone marrow from HLA-identical Sib-
ljngs
Η antigens other than HLA certainly exist. Whether or not thesc non-
HLA determinants play a role in the induction of GVHD remains to be
proven Results which might be of importance in the understanding of the
btological role of non-HLA transplantation Systems and in Us involvcment
in organ transplanlation will be discussed below
In the mouse, the involvement of minor Η antigens in GVH reaction
has been demonstrated [50, 57, 61-63]. The immunogenetics of GVH reac-
tions to minor Η antigens and vanous properties of cells causing GVHD in
mice have lately been summanzed by Korngold and Sprent [64]. Ver> little
is known about the factors which might influence the development of
GVHD following MHC-identical bone marrow transplantation in man
Spaikes et al [107] reported on one such factor a significant correlation was
found between compatibihty for the blood group system MNSs between
donor and recipient and GVHD. Their results suggested that lncompatibil-
lty for the blood group system MNSs may result in GVHD in man
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The detcciion ol a non HLA minor Η antigen as dcscubed abo\c
piompied us lo continue oui scaich for minoi Η antigens and then iolc in
hone manov. tiansplantation The studies weie cained oui in thiec stages
In Uu Inst stagc our goal was thc confirmation and evtension ol oui Inst
asuhs ic ihe gtneiation of CTLs with post-tiansplant l\mprux\ks ol
bone marrow-giaited paticnts and thcir coirelation with the ocunrenee ol
CiV HD in thc sccond stage we uscd the in \itro gcnerated c 1 Ls loi ihe
tdentihcauon o( other minor Η anugens ι e mcreasing the number ot anti
minor Η cellular-t\ping tcag^nts Finalh we used those anti-minoi Η
specific CTLs foi thc retrospective t\ping of HLA-identieal bone matrou
donor recipicnt pairs
Wc studied the post-transplant hmphocues ol 13 HLA-makhed bone
manow rccipients "> with no GVHD 7 with acutc GVHD and 4 with
thronie GVHD The same culture protocol which was succcsstulK used for
generation of anti-minor Η antigen CTLs [42 44] was applied Post-trans-
plant hmphocvtes from recipients of HLA genotvpicalK identical bone
marrow gratts were sensiti/ed in \itro for 6 da\s with thc patient s pie
transplant lymphoc\tes The effector cells harvested at da\ 6 were tested in
the C ML assav foi specific c>totoxic acti\ü> The\ were expanded also in
ordcr to obtain cvtotoxic T-cell hnes Thus large amounts ol t\toto\ic
icagents ma\ be obtained frozen and adequateK used aftcr thawing Table
VII shows thal with post-transplant lymphocUes from D patients 4 ol
whom had chronic GVHD evtotoxicity was observed which was dnectcd
agamst their own pretransplant l\mphoc>tes
In the second stage we tested the in \itro generated CTLs (dem cd
from 5 paticnts) for the identtfication of other minor Η antigens The
anahsis of thc c\toto\ic activitv using a limited panel of target cclls
trom health\ unrelated indi\ iduals identified five different CTL popula-
tions dnected against difterent minor Η antigens The non HL 1 antitftm
(designated minor HA.-1 minor HA-2 minor HA-3 minor HA-4 and
minor HA-5) and the testiutm% MHC molecules necessar\ for their asso-
ciatue recognition are shown in table VII The analysis of the CTL 1
(demed from patient 1) recognizing minor HA-1 in association with
class-I molecules HLA-A2 B27 and Bw62 have been discussed earher
in this chapter and was referred to as minor Η antigen CTLs Another
minor Η antigen (ι e minor HA-2) was recognized b> CTL 2 dem cd
from patient 2 Our scarch for the restncting molecules bv anah/ing the
rvtotoxic activity against a limited number of unrelated target cells has
been unsuccessful so far
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1 ahle ' II Detection ol cell mediated anti-non-HLA acti\it\ after bone marrow gratting
Bone marrow
recipients
( M L Patient HLA nping
No
N O G N H D
AcuteGvHD
ChromcGvHD
0 2
! 6
4 0
1 A2,A2, B27,Bw62, Cwl 3 DR1 4
2 AI All B8,B40 Cw3, DR2 3
3 A2 A3, B18,Bw44, Ο 7 DR4 6
4 A1.A2 B7.B8, Cw7 DR2 3
5 A2 A29 Bw49 Bw44 Cw-, DR5 7
( TLs MHC-reslncting molecules
A2 B27 Bv.62
•« Ap |
A2
A2 Bw44
Non-HLA antigens
minor HA-1
minor HA-2
minor HA-3
minor HA-4
minor HA-5
The results obtained with anti-minor HA-3 CTL 3 from patient 3 mdi-
cate that they possibly recognize not only an HLA-A2-restncted non-HLA
antigenic determinant but also a non-self-HLA class-I alloantigen (i.c
HLA-B8). Thus, HLA-A2 (i.e. selO plus minor HA-3 (i.e. X) equals foreign
HLA (i.e. B8). This might be an example of cross-reactivity earher
descnbed in mouse [10] Yet, analysis on the clonal level has to be carned
out to justify our observation. Recently, cross-reactivity of HLA-restncted
Epstein-Barr virus-specific CTLs for allo-MHC determinants has been
descnbed [30] Analysis of the reactions of CTL 4 obtained from patient 4
identified other minor Η antigen (i.e. minor HA-4) recognized with the
HLA-A2 molecule as restncting element. The HLA-A2- and HLA-Bw44-
restncted CTLs denved from patient 5 recognized a minor Η antigen des-
lgnated minor HA-5. As discussed earlier in this chapter, the minor antigen
H-Y IS preferentially recognized in conjunction with the HLA-A2 and B7
molecule. The recognition of different minor Η antigens (i.e. HA-1, HA-3,
HA-4 and HA-5 as shown in table VII) demonstrate again the preference for
the HLA-A2 class-I molecule for the associative recognition of minor Η
antigens
In our final thnd stage, the large scale expansion of these minor H-
specific CTLs enabled us to störe enough minor Η reagents in order to
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Iahle ί 111 Cellular t\pmg ol human minor Η antigens wuh MHO-restnued anli-minor
H-specilk ( TLs gcneratcd dunng GV HD
Donor icupiems paus
Rccipicnls wiihoul C J V H D
Reupienis wuh acute C J V H D
Recipients uilh (.hrome GVHD
Minor Η
(.ompatibilities1
7
4
%
inLOinpalibihlits1
0
1
1
The donor iecipient pairs arc selected for the presence ol ihe restncting class I
lor required associame recognition ol the minor Η antigens
' No incompdtit»'ities lound belween donor and rccipient Ιοί minor Η \ I to 11 \
b
 Incompdiibilmcs iund betwecn donor and recipien· for Η4-1 to Η \-·>
pro\idc us with t\pmg rcagents Those minor Η c\toto\ic icagents wcie
used to type retrospectivcly a senes of HLA-identical bone manow
donor recipient pairs recipients without GVHD, recipients with acutc
GVHD and recipients with chronic GVHD The results of this anahsis arc
shown in tablc VIII. Also shown are the incompatibilities between HLA-
ldentical bone marrow donors and recipients for minor Η antigens found so
far mainh in the group of patients suffenng from chronic GVHD
Ρ et specin es
Since donors and recipients are routinely selected for identit\ at the
majoi Η System, rejection and GVHD may be caused b\ dispann for the
produets of minor Η Systems The effect of weak transplantation antigens
on allograft survival may hopefully become predictable when CTL-l\ping
reagents at least for the strongest non-MHC transplantation antigens
become avaüable At present no alloimmune sera are available, for the
typing of the non-HLA antigens, which are relevant in the pathogenesis of
GVHD. Consequently, when more than one bone marrow donor IS avail-
able (as well in related as in unrelated situations), CTL typing may mitigate
at least one of the obstacles for successful bone marrow transplantation
Our present goals are. (1) the generation of anti-minor Η CTLs with post-
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iransplant hmphocUes from all available bonc marrow-grafted patients
(2) thc Performance oi extensi\e lmmunogenelic analyses (usmg the results
obtained vvith those anti-mmor Η cytotoxic reagents) which will hopefulh
provide us wnh Information about the a\erage number of human genetic
minor Η loci and their alleles and (3) the investigation of the role of the
\ anous minor Η antigens on the outcome of kidney as well as bone man ov\
transplantation
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